drugset / Trial / NCT01115140

Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women

NCT01115140

Phase 4 Completed 50 enrolled University Magna Graecia
RandomizedParallel-groupTriple-blindPrevention

Summary

A more recent prospective nonrandomized placebo-controlled double-blind clinical study demonstrated that metformin exerts a slight but significant deleterious effect on serum homocysteine (Hcy) levels in patients with PCOS, and supplementation with folate is useful to increase the beneficial effect of metformin on the vascular endothelium.

Timeline

Start
2010-03
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 850 mg
Subject folic acid Other / unclassified 0.4 mg